Gene Therapy Market - Global Outlook and Forecast 2024-2031

Report ID: 1030399 | Published Date: Jan 2025 | No. of Page: 68 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Gene Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Gene Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy Overall Market Size
    2.1 Global Gene Therapy Market Size: 2021 VS 2028
    2.2 Global Gene Therapy Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Gene Therapy Players in Global Market
    3.2 Top Global Gene Therapy Companies Ranked by Revenue
    3.3 Global Gene Therapy Revenue by Companies
    3.4 Top 3 and Top 5 Gene Therapy Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Gene Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy Players in Global Market
        3.6.1 List of Global Tier 1 Gene Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Gene Therapy Market Size Markets, 2021 & 2028
        4.1.2 Viral Gene Therapy
        4.1.3 Non-Viral Gene Therapy
    4.2 By Type - Global Gene Therapy Revenue & Forecasts
        4.2.1 By Type - Global Gene Therapy Revenue, 2017-2022
        4.2.2 By Type - Global Gene Therapy Revenue, 2023-2028
        4.2.3 By Type - Global Gene Therapy Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Gene Therapy Market Size, 2021 & 2028
        5.1.2 Neurological Diseases
        5.1.3 Cancer
        5.1.4 Other
    5.2 By Application - Global Gene Therapy Revenue & Forecasts
        5.2.1 By Application - Global Gene Therapy Revenue, 2017-2022
        5.2.2 By Application - Global Gene Therapy Revenue, 2023-2028
        5.2.3 By Application - Global Gene Therapy Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Gene Therapy Market Size, 2021 & 2028
    6.2 By Region - Global Gene Therapy Revenue & Forecasts
        6.2.1 By Region - Global Gene Therapy Revenue, 2017-2022
        6.2.2 By Region - Global Gene Therapy Revenue, 2023-2028
        6.2.3 By Region - Global Gene Therapy Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Gene Therapy Revenue, 2017-2028
        6.3.2 US Gene Therapy Market Size, 2017-2028
        6.3.3 Canada Gene Therapy Market Size, 2017-2028
        6.3.4 Mexico Gene Therapy Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Gene Therapy Revenue, 2017-2028
        6.4.2 Germany Gene Therapy Market Size, 2017-2028
        6.4.3 France Gene Therapy Market Size, 2017-2028
        6.4.4 U.K. Gene Therapy Market Size, 2017-2028
        6.4.5 Italy Gene Therapy Market Size, 2017-2028
        6.4.6 Russia Gene Therapy Market Size, 2017-2028
        6.4.7 Nordic Countries Gene Therapy Market Size, 2017-2028
        6.4.8 Benelux Gene Therapy Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Gene Therapy Revenue, 2017-2028
        6.5.2 China Gene Therapy Market Size, 2017-2028
        6.5.3 Japan Gene Therapy Market Size, 2017-2028
        6.5.4 South Korea Gene Therapy Market Size, 2017-2028
        6.5.5 Southeast Asia Gene Therapy Market Size, 2017-2028
        6.5.6 India Gene Therapy Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Gene Therapy Revenue, 2017-2028
        6.6.2 Brazil Gene Therapy Market Size, 2017-2028
        6.6.3 Argentina Gene Therapy Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Gene Therapy Revenue, 2017-2028
        6.7.2 Turkey Gene Therapy Market Size, 2017-2028
        6.7.3 Israel Gene Therapy Market Size, 2017-2028
        6.7.4 Saudi Arabia Gene Therapy Market Size, 2017-2028
        6.7.5 UAE Gene Therapy Market Size, 2017-2028
7 Players Profiles
    7.1 Biogen
        7.1.1 Biogen Corporate Summary
        7.1.2 Biogen Business Overview
        7.1.3 Biogen Gene Therapy Major Product Offerings
        7.1.4 Biogen Gene Therapy Revenue in Global Market (2017-2022)
        7.1.5 Biogen Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Gene Therapy Major Product Offerings
        7.2.4 Novartis Gene Therapy Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
    7.3 Gilead Sciences
        7.3.1 Gilead Sciences Corporate Summary
        7.3.2 Gilead Sciences Business Overview
        7.3.3 Gilead Sciences Gene Therapy Major Product Offerings
        7.3.4 Gilead Sciences Gene Therapy Revenue in Global Market (2017-2022)
        7.3.5 Gilead Sciences Key News
    7.4 Sarepta Therapeutics
        7.4.1 Sarepta Therapeutics Corporate Summary
        7.4.2 Sarepta Therapeutics Business Overview
        7.4.3 Sarepta Therapeutics Gene Therapy Major Product Offerings
        7.4.4 Sarepta Therapeutics Gene Therapy Revenue in Global Market (2017-2022)
        7.4.5 Sarepta Therapeutics Key News
    7.5 Alnylam Pharmaceuticals
        7.5.1 Alnylam Pharmaceuticals Corporate Summary
        7.5.2 Alnylam Pharmaceuticals Business Overview
        7.5.3 Alnylam Pharmaceuticals Gene Therapy Major Product Offerings
        7.5.4 Alnylam Pharmaceuticals Gene Therapy Revenue in Global Market (2017-2022)
        7.5.5 Alnylam Pharmaceuticals Key News
    7.6 Amgen
        7.6.1 Amgen Corporate Summary
        7.6.2 Amgen Business Overview
        7.6.3 Amgen Gene Therapy Major Product Offerings
        7.6.4 Amgen Gene Therapy Revenue in Global Market (2017-2022)
        7.6.5 Amgen Key News
    7.7 Spark Therapeutics
        7.7.1 Spark Therapeutics Corporate Summary
        7.7.2 Spark Therapeutics Business Overview
        7.7.3 Spark Therapeutics Gene Therapy Major Product Offerings
        7.7.4 Spark Therapeutics Gene Therapy Revenue in Global Market (2017-2022)
        7.7.5 Spark Therapeutics Key News
    7.8 Akcea Therapeutics
        7.8.1 Akcea Therapeutics Corporate Summary
        7.8.2 Akcea Therapeutics Business Overview
        7.8.3 Akcea Therapeutics Gene Therapy Major Product Offerings
        7.8.4 Akcea Therapeutics Gene Therapy Revenue in Global Market (2017-2022)
        7.8.5 Akcea Therapeutics Key News
    7.9 bluebird bio
        7.9.1 bluebird bio Corporate Summary
        7.9.2 bluebird bio Business Overview
        7.9.3 bluebird bio Gene Therapy Major Product Offerings
        7.9.4 bluebird bio Gene Therapy Revenue in Global Market (2017-2022)
        7.9.5 bluebird bio Key News
    7.10 Sunway Biotech
        7.10.1 Sunway Biotech Corporate Summary
        7.10.2 Sunway Biotech Business Overview
        7.10.3 Sunway Biotech Gene Therapy Major Product Offerings
        7.10.4 Sunway Biotech Gene Therapy Revenue in Global Market (2017-2022)
        7.10.5 Sunway Biotech Key News
    7.11 SIBIONO
        7.11.1 SIBIONO Corporate Summary
        7.11.2 SIBIONO Business Overview
        7.11.3 SIBIONO Gene Therapy Major Product Offerings
        7.11.4 SIBIONO Gene Therapy Revenue in Global Market (2017-2022)
        7.11.5 SIBIONO Key News
    7.12 AnGes
        7.12.1 AnGes Corporate Summary
        7.12.2 AnGes Business Overview
        7.12.3 AnGes Gene Therapy Major Product Offerings
        7.12.4 AnGes Gene Therapy Revenue in Global Market (2017-2022)
        7.12.5 AnGes Key News
    7.13 Orchard Therapeutics
        7.13.1 Orchard Therapeutics Corporate Summary
        7.13.2 Orchard Therapeutics Business Overview
        7.13.3 Orchard Therapeutics Gene Therapy Major Product Offerings
        7.13.4 Orchard Therapeutics Gene Therapy Revenue in Global Market (2017-2022)
        7.13.5 Orchard Therapeutics Key News
    7.14 Human Stem Cells Institute
        7.14.1 Human Stem Cells Institute Corporate Summary
        7.14.2 Human Stem Cells Institute Business Overview
        7.14.3 Human Stem Cells Institute Gene Therapy Major Product Offerings
        7.14.4 Human Stem Cells Institute Gene Therapy Revenue in Global Market (2017-2022)
        7.14.5 Human Stem Cells Institute Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Gene Therapy Market Opportunities & Trends in Global Market
    Table 2. Gene Therapy Market Drivers in Global Market
    Table 3. Gene Therapy Market Restraints in Global Market
    Table 4. Key Players of Gene Therapy in Global Market
    Table 5. Top Gene Therapy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Gene Therapy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Gene Therapy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Gene Therapy Product Type
    Table 9. List of Global Tier 1 Gene Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Gene Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Gene Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Gene Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Gene Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Gene Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Gene Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Gene Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Gene Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Gene Therapy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Gene Therapy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Gene Therapy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Gene Therapy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Gene Therapy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Gene Therapy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Gene Therapy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Gene Therapy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Gene Therapy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Gene Therapy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Gene Therapy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Gene Therapy Revenue, (US$, Mn), 2023-2028
    Table 30. Biogen Corporate Summary
    Table 31. Biogen Gene Therapy Product Offerings
    Table 32. Biogen Gene Therapy Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis Corporate Summary
    Table 34. Novartis Gene Therapy Product Offerings
    Table 35. Novartis Gene Therapy Revenue (US$, Mn), (2017-2022)
    Table 36. Gilead Sciences Corporate Summary
    Table 37. Gilead Sciences Gene Therapy Product Offerings
    Table 38. Gilead Sciences Gene Therapy Revenue (US$, Mn), (2017-2022)
    Table 39. Sarepta Therapeutics Corporate Summary
    Table 40. Sarepta Therapeutics Gene Therapy Product Offerings
    Table 41. Sarepta Therapeutics Gene Therapy Revenue (US$, Mn), (2017-2022)
    Table 42. Alnylam Pharmaceuticals Corporate Summary
    Table 43. Alnylam Pharmaceuticals Gene Therapy Product Offerings
    Table 44. Alnylam Pharmaceuticals Gene Therapy Revenue (US$, Mn), (2017-2022)
    Table 45. Amgen Corporate Summary
    Table 46. Amgen Gene Therapy Product Offerings
    Table 47. Amgen Gene Therapy Revenue (US$, Mn), (2017-2022)
    Table 48. Spark Therapeutics Corporate Summary
    Table 49. Spark Therapeutics Gene Therapy Product Offerings
    Table 50. Spark Therapeutics Gene Therapy Revenue (US$, Mn), (2017-2022)
    Table 51. Akcea Therapeutics Corporate Summary
    Table 52. Akcea Therapeutics Gene Therapy Product Offerings
    Table 53. Akcea Therapeutics Gene Therapy Revenue (US$, Mn), (2017-2022)
    Table 54. bluebird bio Corporate Summary
    Table 55. bluebird bio Gene Therapy Product Offerings
    Table 56. bluebird bio Gene Therapy Revenue (US$, Mn), (2017-2022)
    Table 57. Sunway Biotech Corporate Summary
    Table 58. Sunway Biotech Gene Therapy Product Offerings
    Table 59. Sunway Biotech Gene Therapy Revenue (US$, Mn), (2017-2022)
    Table 60. SIBIONO Corporate Summary
    Table 61. SIBIONO Gene Therapy Product Offerings
    Table 62. SIBIONO Gene Therapy Revenue (US$, Mn), (2017-2022)
    Table 63. AnGes Corporate Summary
    Table 64. AnGes Gene Therapy Product Offerings
    Table 65. AnGes Gene Therapy Revenue (US$, Mn), (2017-2022)
    Table 66. Orchard Therapeutics Corporate Summary
    Table 67. Orchard Therapeutics Gene Therapy Product Offerings
    Table 68. Orchard Therapeutics Gene Therapy Revenue (US$, Mn), (2017-2022)
    Table 69. Human Stem Cells Institute Corporate Summary
    Table 70. Human Stem Cells Institute Gene Therapy Product Offerings
    Table 71. Human Stem Cells Institute Gene Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Gene Therapy Segment by Type in 2021
    Figure 2. Gene Therapy Segment by Application in 2021
    Figure 3. Global Gene Therapy Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Gene Therapy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Gene Therapy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy Revenue in 2021
    Figure 8. By Type - Global Gene Therapy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Gene Therapy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Gene Therapy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Gene Therapy Revenue Market Share, 2017-2028
    Figure 12. US Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Gene Therapy Revenue Market Share, 2017-2028
    Figure 16. Germany Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 17. France Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Gene Therapy Revenue Market Share, 2017-2028
    Figure 24. China Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 28. India Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Gene Therapy Revenue Market Share, 2017-2028
    Figure 30. Brazil Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Gene Therapy Revenue Market Share, 2017-2028
    Figure 33. Turkey Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Gene Therapy Revenue, (US$, Mn), 2017-2028
    Figure 37. Biogen Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Gilead Sciences Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Sarepta Therapeutics Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Alnylam Pharmaceuticals Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Amgen Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Spark Therapeutics Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Akcea Therapeutics Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. bluebird bio Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Sunway Biotech Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. SIBIONO Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. AnGes Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Orchard Therapeutics Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Human Stem Cells Institute Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Gene Therapy Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gene Therapy Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gene Therapy Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports